Literature DB >> 9256850

Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults.

M W Rich1.   

Abstract

OBJECTIVES: To review the epidemiology, pathophysiology, and etiology of congestive heart failure (CHF) in older adults.
METHODS: Published reports relevant to the epidemiology, pathophysiology, and etiology of CHF were systematically reviewed. Studies involving older adults and more recent studies were emphasized.
RESULTS: More than 75% of patients with CHF in the United States are older than 65 years of age, and CHF is the leading cause of hospitalization in older adults. CHF is also a major cause of chronic disability, and annual expenditures for CHF currently exceed $10 billion. In addition, both the incidence and prevalence of CHF are increasing, largely as a result of the aging of the population. Older adults are predisposed to developing CHF as a result of age-related changes in the cardiovascular system and the high prevalence of hypertension, coronary artery disease, and valvular heart disease in this age group. Although the fundamental pathophysiology of CHF is similar in younger and older patients, older individuals are more prone to develop CHF in the setting of preserved left ventricular systolic function. This syndrome, referred to as diastolic heart failure, accounts for up to 50% of all cases of CHF in adults more than 65 years of age. Coronary heart disease and hypertension are the most common etiologies of CHF in older adults, and they often coexist. Valvular heart disease, especially aortic stenosis and mitral regurgitation, are also common in older adults, whereas nonischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy occur less frequently.
CONCLUSIONS: Congestive heart failure is a major public health problem in the United States today as a result of its high and increasing prevalence in the older population as well as its substantial impact on healthcare costs and quality of life. There is an urgent need to develop more effective strategies for the prevention and treatment of CHF in older individuals.

Entities:  

Mesh:

Year:  1997        PMID: 9256850     DOI: 10.1111/j.1532-5415.1997.tb02968.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  47 in total

Review 1.  LV hypertrophy and diastolic heart failure.

Authors:  S Betocchi; O M Hess
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

Review 2.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 3.  β-Adrenergic receptor subtype signaling in heart: from bench to bedside.

Authors:  Anthony Yiu Ho Woo; Rui-ping Xiao
Journal:  Acta Pharmacol Sin       Date:  2012-01-30       Impact factor: 6.150

4.  Disability in the oldest-old: incidence and risk factors in the 90+ study.

Authors:  Daniel J Berlau; Maria M Corrada; Carrie B Peltz; Claudia H Kawas
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

5.  Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure.

Authors:  Hakki Kaya; Recep Kurt; Osman Beton; Ali Zorlu; Hasan Yucel; Hakan Gunes; Didem Oguz; Mehmet Birhan Yilmaz
Journal:  Tex Heart Inst J       Date:  2017-02-01

Review 6.  Heart failure treatments: issues of safety versus issues of quality of life.

Authors:  J Feenstra; J Lubsen; D E Grobbee; B H Stricker
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

7.  Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure.

Authors:  Vishnu K Rumalla; Steve E Calvano; Alan J Spotnitz; Tyrone J Krause; Robert J Hilkert; Edward Lin; Stephen F Lowry
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

Review 8.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

9.  Reduced peripheral arterial blood flow with preserved cardiac output during submaximal bicycle exercise in elderly heart failure.

Authors:  Chirapa Puntawangkoon; Dalane W Kitzman; Stephen B Kritchevsky; Craig A Hamilton; Barbara Nicklas; Xiaoyan Leng; Peter H Brubaker; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-18       Impact factor: 5.364

Review 10.  Candesartan in heart failure.

Authors:  Toni L Ripley; Jennifer S Chonlahan; Robin E Germany
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.